CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
The information required in these declarations include product information (name, strength, dosage form), manufacturer, packager and license holder, and drug product manufacturing site name and country. Although ANVISA has been an ICH member since 2016, the implementation plan of ICH guidelines is still ongoing. Position paper.
52 
Let's personalize your content